0001209191-16-115258.txt : 20160421 0001209191-16-115258.hdr.sgml : 20160421 20160421212709 ACCESSION NUMBER: 0001209191-16-115258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160419 FILED AS OF DATE: 20160421 DATE AS OF CHANGE: 20160421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 6503662626 MAIL ADDRESS: STREET 1: 123 SAGINAW DRIVE STREET 2: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosen Robert CENTRAL INDEX KEY: 0001555089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 161585139 MAIL ADDRESS: STREET 1: C/O A.P. PHARMA, INC., 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-04-19 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001555089 Rosen Robert 123 SAGINAW DRIVE REDWOOD CITY CA 94063 1 1 0 0 President Common Stock 2016-04-19 4 M 0 176328 7.20 A 178968 D Common Stock 2016-04-19 4 S 0 60925 22.4964 D 118043 D Common Stock 2016-04-19 4 S 0 76949 23.4695 D 41094 D Common Stock 2016-04-19 4 S 0 32224 24.486 D 8870 D Common Stock 2016-04-19 4 S 0 6230 25.1104 D 2640 D Common Stock 2016-04-20 4 M 0 4010 7.20 A 6650 D Common Stock 2016-04-20 4 S 0 4010 22.1864 D 2640 D Common Stock 2016-04-21 4 M 0 19662 7.20 A 22302 D Common Stock 2016-04-21 4 S 0 19662 22.1459 D 2640 D Employee Stock Option (Right to Buy) 7.20 2016-04-19 4 M 0 176328 0.00 D 2023-05-01 Common Stock 176328 948672 D Employee Stock Option (Right to Buy) 7.20 2016-04-20 4 M 0 4010 0.00 D 2023-05-01 Common Stock 4010 944662 D Employee Stock Option (Right to Buy) 7.20 2016-04-21 4 M 0 19662 0.00 D 2023-05-01 Common Stock 19662 925000 D The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of August 20, 2015. The range of sales prices received was $22.00 to $23.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $23.01 to $24.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $24.02 to $25.00. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $25.01 to $25.30. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $22.00 to $22.53. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. The range of sales prices received was $22.00 to $22.32. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. At the date of filing, 410,157 shares of the options granted pursuant to the underlying awards were fully vested and exercisable. /s/ Brian Drazba Attorney-in-fact for Robert Rosen 2016-04-21